QUSVM
Qiming U.S. Ventures Management Portfolio holdings
AUM
$23.6M
This Quarter Return
+3.04%
1 Year Return
-18.39%
3 Year Return
+715.34%
5 Year Return
–
10 Year Return
–
AUM
$51.1M
AUM Growth
+$51.1M
(-0.42%)
Cap. Flow
-$5.4M
Cap. Flow
% of AUM
-10.55%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Kezar Life Sciences
KZR
|
$5.01M |
| 2 |
HilleVax
HLVX
|
$386K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Jasper Therapeutics
JSPR
$45.5M
| $19.9M | 38.83% |
928,964
| – | – |
|
2
Tourmaline Bio
TRML
$601M
| $15M | 29.41% |
741,691
| – | – |
|
3
Korro Bio
KRRO
$217M
| $14M | 27.4% |
368,085
| – | – |
|
4
Ventyx Biosciences
VTYX
$171M
| $903K | 1.77% |
412,225
| – | – |
|
|
5
HilleVax
HLVX
$105M
| $771K | 1.51% |
372,615
-186,308
| -33% | -$386K |
|
|
6
Kezar Life Sciences
KZR
$28.9M
| $557K | 1.09% |
82,871
-745,840
| -90% | -$5.01M |
|